Launchpad is the largest angel investing group in the Northeast, with a broad base of very active members coming from a variety of backgrounds and professions, including the technology, financial service, industrial and life science communities. Launchpad is a top-five ranked angel group in the US by both deal volume and dollars invested. As a group, we are well-connected to potential customers, service providers, partners and future sources of financing. Our members are accredited investors who are proven business leaders with experience and skills from a broad range of industries and professions. Launchpad members bring the financial resources, talent, knowledge and experience, networking contacts, domain-specific expertise, and energy and enthusiasm start-ups need in order to succeed. The one thing that unites this diverse group is a shared passion for helping interesting companies thrive through investment, mentorship, introductions and advice.
Hambleton Lord has 25 years experience in the software industry. Ham is Managing Director of Launchpad Venture Group. Ham is an investor and advisor to early stage companies.
He is a board member for Qstream and Cambridge Trust and a board observer for Building Engines, Repsly and EveryScape.
Ham co-founded data visualization vendor, Advanced Visual Systems. Ham helped launch two computational chemistry companies, MicroChem Technologies and Polygen. These companies were early developers of drug discovery tools, and were part of an industry wide acquisition roll-up that resulted in Accelrys.
Ham graduated with a degree in computer science from Brown University.
Christopher Mirabile is the co-Managing Director of LaunchPad Venture Group. Christopher is a full-time angel and an active member of the Boston-area angel investing community with investments in more than 40 start-up companies. He was named one of XConomy's "Top Angel Investors in New England" for 2012.
Christopher is an adjunct lecturer in the MBA program at Babson College, a regular advisor and mentor to start-ups, and a frequent panelist and speaker. He is a member of the Board of Directors or Board of Advisors of numerous start-up companies as well as several non-profits, and he is an Entrepreneur-in-Residence at Babson's Olin School of Business.
Christopher has served as a public company CFO with IONA Technologies PLC, a corporate and securities lawyer with Testa Hurwitz & Thibeault and as a management consultant with Price Waterhouse's Strategic Consulting Group.
Christopher earned his J.D. from Boston College Law School and his B.A., with honors, from Colgate University.
Jodi Collier has over 10 years of marketing and operations experience in the education and manufacturing industries. She has worked at Champion International Paper Company and EF Education.
Jodi graduated from Emory College with a degree in political science and earned her M.B.A. from the College of William and Mary.
Bill Contente was one of the first members of Launchpad, and currently serves as Chairman of Launchpad's Board of Directors. He's also a senior partner, and a former Managing Partner, of Gesmer Updegrove LLP, a law firm focused on the needs of emerging technology and medical device companies. Bill is a corporate lawyer, providing clients with strategic and legal advice, practical business guidance and value-added services that drive revenue and increase profitability. He has helped position hundreds of companies for financing, evaluating their business models, financing plans and prospects for success. As part of his “day job,” Bill is involved in all aspects of financing and M&A transactions, including venture capital financings, angel financings and successful exits. Most of Bill’s clients are emerging companies, ranging from raw start-ups to companies with $50,000,000+ in revenues. With an extensive network, Bill is constantly opening doors and making connections that add to his clients’ capabilities and successes.
In addition to his professional life, Bill is a guitar player, paraglider, swimmer and sometime photographer. He lives in Newton with his wife Sue.
Prior to TruTouch, Dr. Gill was most recently President & CEO of ProNAi Therapeutics, a cancer therapy development company with a DNAi oncology drug now in the clinic. Prior to ProNAi, Dr. Gill was President and CEO of Signet Laboratories, Inc. an evidence-based medicine company commercializing predictive reagents, diagnostics and preventive drugs and therapies, which was acquired by Covance. Dr. Gill was also President and CEO at AnVil Inc. a venture-backed in silico drug-discovery company; President and CEO at ActiveCyte, a venture-backed decision support service and licensing exchange for the global bio-pharmaceutical industry, which was acquired by Wolters Klower; President and COO at Genome Therapeutics; where he took the company through follow on financing (now NASDAQ. OSCI); SVP & General Manager of British Technology Group, establishing BTG USA in North America & taking the company public (BGC.LON); and started his career as Company Research and Development Manager at Unilever.
Dr. Gill holds a Ph.D. in Endocrinology and a B.Sc. with honors in Physiology and Biochemistry from Reading University, UK.
Gail Greenwald is an active seed-level investor and an experienced senior executive with more than 25 years’ experience in technology-intensive companies. In addition to her role on Launchpad’s board, she is currently a member of the Clean Energy Venture Group, an advisory board member of The Capital Network, and a board member or observer for two portfolio companies.
Formerly, Gail was executive vice president of Foliage, where she was responsible for corporate-wide P&L management and relationship management for major accounts. Prior to Foliage, Gail spent five years as chief operating officer of Caveo Technology, an entrepreneurial company focused on advanced motion detection systems. Earlier in her career, Gail spent seventeen years at Arthur D. Little, where she was vice president and senior managing director of the company’s technology and product development group.
Gail holds a B.S. in chemical engineering from MIT and a PhD in chemical engineering from the University of California at Berkeley.
Catherine Mannick is General Counsel and Chief Administrative Officer of AcadiaSoft, Inc., a financial services software company with operations in the US and Western Europe. Prior to joining AcadiaSoft, she served as Executive Vice President and General Counsel of Cole Management Incorporated, a fund that invested in Russian and other emerging market technology companies. Before joining Cole Management, she served as Vice President and Assistant General Counsel of The Pioneer Group, Inc., a NASDAQ listed financial services company, and General Counsel of its spin-off, Harbor Global Company Ltd., an OTC listed company that was organized to manage Pioneer’s portfolio of investments in Russia and Eastern Europe. Previously, she co-chaired the Russian Practice Group at Hale and Dorr, LLP and served as international counsel at Bank of Boston.
Ms. Mannick is a member and Director of Launchpad Venture Group, a Boston area angel investing group focused on early stage investments primarily in high tech and life sciences. She is also a Director of the Rostropovich Vishnevskaya Foundation and CRDF Global.
Ms. Mannick holds a B.A. in Russian Studies from Yale University, an M.A. in History from Harvard University and a J.D. from Harvard Law School, and has studied law as a postgraduate at Moscow State University.
R. Gregg Stone has been active in the investment business for over forty years from the seed stages of companies’ development as an angel investor and board member to helping guide substantial charitable endowments. Gregg currently serves as the Chairman of PHT Corp., a pharmaceutical service company based in Charlestown, Massachusetts and serves as a director of Cambridge Trust Company and two private companies. Before founding Kestrel in 1996, Gregg worked at Pell, Rudman & Co. Inc. (now Atlantic Trust Company), a Boston-based investment adviser, after practicing law with Hemenway & Barnes in Boston. He holds J.D. and A.B. degrees from Harvard. He is a director of the Boys & Girls Clubs of Boston and Camp Pasquaney and a trustee emeritus of the Beth Israel Deaconess Medical Center.